DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Immune Thrombocytopenic Purpura | Treatment Algorithms: Claims Data Analysis | US | 2020
Immune thrombocytopenic purpura (ITP) has a complex treatment algorithm comprising many therapies, different combinations of which serve as first-, second-, and later-line treatments. Key…
Non-Small-Cell Lung Cancer | Current Treatment: Physician Insights | EU5 | 2020
The current treatment algorithm for non-small-cell lung cancer (NSCLC) is rapidly evolving. The increasing number of biomarker-driven therapies has resulted in a highly segmented space dominated by…
Axial Spondyloarthritis | Access & Reimbursement | US | Ankylosing Spondylitis and Non-Radiographic AxSpA | 2020
The axial spondyloarthritis (AxSpA) therapy market includes biologics from two distinct drug classes: the tumor necrosis factor-alpha (TNF-α) inhibitors (Amgen’s Enbrel, AbbVie’s Humira,…